Bioanalytical Laboratories
Transcription
Bioanalytical Laboratories
B I O A N A LY T I C A L L A B O R AT O R I E S BIOANALYTICAL LABORATORIES At PRA Health Sciences, we recognize that the world of clinical development is complex and dynamic, and we’ve designed our bioanalytical laboratories to meet those challenges. Proactive with our science and always looking to the future, we provide the technology, innovative approaches, and high scientific standards required to deliver industry-leading laboratory services. “The proximity of our labs to our clinics allows us to handle the most time-critical sample analysis.” PETER KETELAAR, Vice President, Bioanalytical Laboratory Services EXPERIENCE PRA’s GLP-compliant laboratories are strategically located close to our Phase I Clinical Research Centers to foster innovative cross-functional team collaboration and to facilitate rapid analyses of time-critical samples. Our early phase environment enables clients to advance studies to the next phase much faster and clearly differentiates our bioanalytical laboratories and clinical pharmacology units as centers of excellence. EXPERTISE N o . O F YE A RS P ROVI D I NG B IO A N ALYTI CA L SE RVI CE S 30 2 25 PRA’s bioanalytical laboratories are managed, staffed, and supported by industry-leading experts who have the scientific knowledge and experience necessary to successfully deliver the most complex of studies. G L OBA L P K / P D B IOA NA LY T IC A L S E RV IC E S Laboratories in the US and The Netherlands • harmonized • GLP compliant • Watson LIMS Close to Phase I clinics to facilitate complex adaptive trials Pharmaceutical analysis at QC lab for drug manufacturing Isotope analysis to support human ADME study designs N o . O F G L OB A L HA R MONIZED B IO A N ALYTI CA L LA B S A SSEN, NL L E NE XA, U SA N o . O F LC -MS/ MS MAC HINES small molecules Flow Cytometry laboratory to evaluate early efficacy Cell-based assay lab to demonstrate immunogenicity 1,000+ validated methods I N N O VAT I O N We provide analytical capabilities for small and large molecules supporting GLP pre-clinical and Phase I-IV clinical trials. Our GLP-compliant facilities adhere to the latest stringent global regulatory guidelines (e.g. FDA and EMA) and expectations. Our technology investments and innovative service offerings are a key component of our goals and strategies for developing solutions for our clients. SERVICE OFFERINGS OUR SCIENTIFIC EXPERTISE MAKES THE COMPLEX, SIMPLE. Biohazard laboratory to handle infectious samples LARGE MOLECULES LC-MS/MS, including ABSciex 6500 HPLC & UPLC Equipment Ligand Binding Assays Clinical Chemistry Laboratory (Stimulation assays, enzymatic activity) Flow Cytometry Unit Radioisotope Laboratory Biohazard Laboratory PK of Small Molecules PK of Large Molecules Immunogenicity Assays Biomarker/PD Assays GMP Pharmaceutical Analysis Co-located with PRA Clinic EUROPE NORT H A M ERICA Global Facilities Our harmonized global facilities enable our clients who use both of PRA's bioanalytical laboratories to benefit from transferring assay methods (small and large molecules) between Europe and the US. No one understands the daily pressure of tight deadlines better than the people who depend on and help drive clinical drug research – from the millions of patients worldwide to the devoted scientists who work tirelessly on their behalf. At PRA, our bioanalytical laboratory teams know that in today's environment, a spared moment could mean a missed opportunity to get even a step closer to advancing meaningful treatments to market. To maximize time in early phase clinical research, we have located our laboratories near our Phase I units and developed harmonized operating procedures with all of our early stage clinics. We are motivated by the role we play helping to get safe and effective treatments to patients. And we are inspired knowing that with our clients, we are giving patients more time to spend with loved ones. PRA PRA Health Health Sciences Sciences conducts conducts comprehensive comprehensive Phase phase I-IV I-IV biopharmaceutical biopharmaceutical drug drug development. development. To To learn learn more more about about our our solutions, solutions, please please visit visit us us at at prahs.com prahs.com or or email email us us at at [email protected]. [email protected].